[1]
Rasool, A.M.A., Rashid, A.M.S., Hassan , E.H.A. and Subhi, A. 2025. REPURPOSING ORLISTAT AS A FATTY ACID SYNTHASE INHIBITOR IN BREAST CANCER: IN VITRO EFFICACY, MECHANISMS, AND SYNERGY WITH DOXORUBICIN. Journal of Medical Genetics and Clinical Biology. 3, 1 (Dec. 2025), 73–89. DOI:https://doi.org/10.61796/jmgcb.v3i1.1606.